The compact Allerject epinephrine auto-injector will relaunch across the Canada as of May 19, the pharmaceutical maker Kaléo has announced.… Read more »
The last time that Clarence Sullivan, owner of The Pharmacy Shop in Lexington, Kentucky, received a shipment of Mylan NV’s… Read more »
Updated Aug. 21, 2018: An online survey of epinephrine auto-injector access, conducted by the Food Allergy Research & Education (FARE),… Read more »
While the FDA estimated that the shortage of the EpiPen and two generic epinephrine auto-injectors would be “short-term,” a major… Read more »
Updated June 15, 2018. Branded and generic epinephrine auto-injectors distributed in the U.S. by Mylan NV are officially in shortage because… Read more »
For the latest update on the EpiPen shortage in the U.S., see Allergic Living’s article here. Many American families and… Read more »
The FDA has approved the first-ever epinephrine auto-injector designed for infants and small children who weigh between 16.5 to 33… Read more »
Drug maker Kaléo promises low consumer payout, but list price may spark controversy.
Company says details of “when and how best to bring Auvi-Q back to the market” still being worked out.